Literature DB >> 712586

Influence of food and fluid ingestion on aspirin bioavailability.

P A Koch, C A Schultz, R J Wills, S L Hallquist, P G Welling.   

Abstract

The influence of test meals and accompanying fluid volume on aspirin bioavailability from commercial tablets was determined following single oral doses to healthy male volunteers. Plasma aspirin and salicylate levels were determined simultaneously using a GLC end-point. Area analysis indicated that approximately 5--8% of absorbed drug entered the systemic circulation as unchanged aspirin in nonfasted subjects compared to 16--18% in fasted individuals. Food tended to reduce the appearance rate of aspirin into the circulation, resulting in lower and somewhat more sustained levels than with fasting. Plasma salicylate levels were not influenced markedly by the various treatments, although levels were higher in fasted than in nonfasted subjects during the 1st hr after dosing. After this time, fat pretreatment tended to produce higher levels than other treatments.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712586     DOI: 10.1002/jps.2600671110

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

1.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

2.  Estimate of volume/flow ratio of gastrointestinal (GI) fluids in humans using pharmacokinetic data.

Authors:  P Macheras; C Reppas; J B Dressman
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

3.  Structural identifiability of "first-pass" models.

Authors:  A Venot; E Walter; Y Lecourtier; A Raksanyi; L Chauvelot-Moachon
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

Review 4.  The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-10-01

5.  Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.

Authors:  M S Roberts; R H Rumble; S Wanwimolruk; D Thomas; P M Brooks
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

7.  Drug metabolite concentration-time profiles: influence of route of drug administration.

Authors:  J B Houston; G Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

8.  Aspirin pharmacokinetics in migraine. The effect of metoclopramide.

Authors:  L M Ross-Lee; M J Eadie; V Heazlewood; F Bochner; J H Tyrer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Systemic availability of acetylsalicylic acid in normal men and women and its effect on in vitro platelet aggregability.

Authors:  S E Husted; A K Pedersen; T Petersen; E Geday
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis.

Authors:  T S Tracy; T Worster; J D Bradley; P K Greene; D C Brater
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.